Browsing Tag
Novo Nordisk
103 posts
Novo Nordisk stock climbs 1.52% as obesity drug Liraglutide shows promise in young kids
Novo Nordisk A/S shares climbed by 1.52% today to 888.60 DKK, following the release of promising new data…
Setback for diabetes innovation: FDA puts brakes on Novo Nordisk’s once-weekly insulin icodec
Novo Nordisk announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)…
Novo Nordisk faces setback as CLARION-CKD trial fails, leading to significant financial impairment
Novo Nordisk, a global leader in pharmaceuticals, has announced a major setback as its CLARION-CKD phase 3 trial…
Novo Nordisk announces $4.1bn investment in new North Carolina manufacturing facility
Novo Nordisk, a global leader in pharmaceutical manufacturing, has unveiled plans to invest $4.1 billion (approximately 27 billion…
Novo Nordisk announces significant outcomes for Mim8 in FRONTIER 2 trial
Novo Nordisk, a global healthcare leader, has announced significant outcomes from the FRONTIER 2 trial, a pivotal phase…
Novo Nordisk to acquire Cardior Pharmaceuticals to expand cardiovascular portfolio
In a significant move within the pharmaceutical industry, Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up…
FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity
The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk’s Wegovy, a…
Novo Nordisk announces $11bn acquisition of fill-finish sites to boost global manufacturing
In a strategic move to enhance its global manufacturing capabilities, Novo Nordisk has announced a significant acquisition from…
Novo Nordisk announces major expansion of Chartres manufacturing site in France
Novo Nordisk, a global healthcare leader, has announced a significant investment exceeding 16 billion Danish kroner (2.1 billion…
Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments
Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a…